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Abstract: In this investigation, a new nanocomposite as a nanocarrier based on functionalized graphene oxide was synthesized by
reaction of tetraethylenepentamine and chlorosulfonic acid with functional groups on the surface of GO. The synthesized nanocomposite
was characterized by FT-IR, XRD TGA, FE-SEM, EDAX, TEM, and AFM analysis. To explore the potential of nanocomposites in drug
delivery, the loading and releases of quercetin as an anticancer drug were investigated. The result displayed that more than 90% of the
drug was loaded on the nanocarrier and the release of the drug is depending on the pH of the environment such that the releases of the
drug in Gastric and intestinal conditions were up to 50% and 30%, respectively. The analysis of toxicity effect on the normal and cancer
cells indicated that the nanocarrier with the drug has potential for cancer cells therapy without cytotoxic effect on normal cells in IC50
concentration.
Key words: Nanocomposite, nanocarrier, drug delivery, cytocompatibility

1. Introduction
Research on graphene and graphene oxide (GO) has been widespread and impressive in biomedical applications in new
days due to particular properties including two-dimensional flat structure, high mechanical and chemical stability, low
toxicity, and good biocompatibility. These properties provide an encouraging method towards designing, advanced drug
delivery systems, offer a new class of graphene-based nanomaterial [1–4]. However, as a disadvantage for application,
graphene has a high tendency for aggregation duo to interlayers interaction. GO is synthesized from graphene by an
oxidation process that produces a versatile material with –COOH, epoxy and –OH functional groups on two sides sheets
and edges [5]. These functional groups facilitate exfoliation of GO in different media to create homogeneous solutions that
improve the application of GO in different fields such as drug delivery and elimination of the environmental pollutions
on the basis of non/covalent bonding e.g., hydrogen bonding and electrostatic interactions [6–10]. Among groups for
functionalization, the –NH2 is a good candidate with simple chemical modification. Functionalization of reactive surface
amine is a convenient method in many studies for the synthesis of modified GO for application in optoelectronic,
biodevices, polymer composites, and drug delivery [11–13]. Several groups have focused on the functionalization of GO
as a nanocarrier for drug delivery, because of its high potential chemical versatility [14–17]. Zhang et al., for instance,
prepared a nanocomposite based on functionalized GO for coloading of camptothecin (CPT) and doxorubicin. Their
study displays that the nanocomposite has a high ability for loading of two medicine and good efficiency on the cancer cell
compared with pure GO [18].
Quercetin (QCN) is a bioflavonoid that is found in many vegetables and fruits. This natural organic substance exhibits
pharmacological properties such as antiinflammatory and anticancer properties due to the absorption of free radicals
[19–21]. But, the therapeutic application of this medicine is limited due to some inappropriate properties such as poor
solubility in water and low stability and bioavailability. To overcome the mentioned problems, a practical procedure is
the use of nanocarriers including GO[22], chitosan, and liposomes [23–26]. There are some studies on the application
of nanomaterials for QCN delivery. However, studies on the modified GO as a drug delivery system for QCN are very
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rare. Accordingly, in the present work, we aim to prepare a modified GO as a nanocarrier with the potential of loading
and sustaining release for QCN. In addition, the cytotoxic effect of drug and nanocarrier with the drug compared on
human normal and cancer cells. As a novelty, the tetraethylenepentamine and chlorosulfonic were used to functionalize
the surface of GO with several hydrogen bonding and active site to make it suitable for proper loading of (QCN) as an
anticancer drug.
2. Materials and methods
2.1. Materials
Graphite, sulfuric acid (98%), phosphoric acid (98%) potassium permanganate, hydrogen peroxide (30 wt.%), hydrochloric
acid (38%), ethanol (95%), methanol, acetone, tetraethylenepentamine (TEPA), chlorosulfonic acid, dichloromethane,
quercetin (QC), and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma
(USA). Dimethyl sulfoxide was purchased from Merck company. All the reagents utilized in this article had analytical
grades and without further purification. The human colorectal adenocarcinoma cell lines (HT29) were bought from the
Pasteur Institute, (Tehran, Iran). The human dermal fibroblast cells (HDF) as a normal cell, isolated from human newborn
foreskins at 1 month of age that underwent routine circumcision in Amirkola Children’s Hospital (Babol, Iran).
2.2. Preparation of GO
A modified Hummers method was used to synthesize GO from natural graphite [27]. In a common procedure, H2SO4
(120 mL) and H3PO4 (13 mL) were poured into a three-neck flask then graphite (1 g) was added and stirred at ambient
temperature for 24 h. After that KMnO4 (7.0 g) was slowly entered into the flask for 70 min at 60 °C. The mixture was
stirred for 6 h at 60 °C and then was cooled to less than 5 °C. After that, 200 mL of deionized water and 4 mL of 30% aq
H2O2 were added to it. Yellow sediment was obtained. To remove the remaining salt, sediment was washed with HCl 10%
(100 mL) and deionized water (2000 mL). Finally, the solid was separated by centrifuge and dried at 70 °C in an oven for
24 h.
2.3. Preparation of GO-TEPA
The mixture of GO (200 mg) and tetraethylenepentamine (3 mL) in ethanol (80 mL 98%) was dispersed by sonication with
an ultrasonic apparatus for 80 min and stirring for 48 h at room temperature. Then, nanoparticle suspensions were removed
from the solution by filtration, and then washed several times with ethanol, then dried in an oven at 70 °C for 24 h.
2.4. Preparation of GO-TEPA-SO3H
GO-TEPA (200 mg) was taken in 5 mL of dry dichloromethane in a round bottom flask, then sonicated for 60 min and
stirred for 45 min. Subsequently, concentrated chlorosulfonic acid was poured into 15 mL dry dichloromethane and added
slowly to the mixture for about 45 min under stirring at 0 °C. After 4h stirring at room temperature, the suspension was
filtrated, washed with ethanol and then vacuum dried for 48 h [28–30].
2.5. Measurements
Fourier transform infrared (FT-IR) analysis was taken on a Bruker Tensor 27 Spectrometer (Bruker, Karlsruhe, Germany).
X-ray diffraction patterns (XRD, Shibuya-ku, Japan) were collected at room temperature on a RigakuD/Max-2550 powder
diffractometer by scanning at a rate of 5°/min, in the range of 2Ɵ = 5–70 °C. The surface morphology of the materials was
assessed using scanning electron microscopy (Hitachi S4160 model, Tokyo, Japan) fitted with an energy dispersive X-ray
analyzer (EDAX). Using the LENSES STAPT-1000 calorimeter (Germany) under N2 atmosphere, thermal gravimetric
analysis (TGA) was conducted in the temperature range of 30–800 °C at a heating rate of 10 °C/min. Transmission electron
microscopy (TEM) images were obtained using JEOL2100F. Atomic force microscope (AFM) images were recorded using
an ICON atomic force microscope (BRUKER) in tapping mode. Raman spectroscopy was taken on the Terkam apparatus
equipped with a 532 nm laser and 30mW of power.
2.6. Quercetin loading
A hundred mg of GO-TEPA-SO3H as a carrier was dispersed in 50 mL of QCN (100 ppm) in ethanol and stirred for 24 h
at 25 °C. The solid that contains quercetin loaded on the carrier was separated by centrifuge for 20 min at 3200 rpm and
dried in a vacuum desiccator for 24 h. In the following, the amount of unloaded drug in the supernatant was measured
with a PG instruments T80 UV-Visible spectrophotometer at 375 nm (λ max of QCN).
2.7. Release of QCN from GO- TEPA-SO3H
The released values of QCN from GO- TEPA-SO3H were measured at 37 °C by dialysis bag at two different pH. The GOTEPA-SO3H-QCN (30 mg) was poured into a phosphate buffer saline solution (PBS) (10 mL, pH 1.2, and 7.4), then it was
transferred into the two dialysis bags, and then they were placed in the PBS solution (30 mL) with the similar pH separately
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under stirring (200 rpm) at 37 °C. After that, a certain volume was taken from the vessel after a specific time, and the same
volume of fresh PBS was added to the vessel to ensure a constant total volume. The values of QCN were estimated up to 96
h by a uv–vis spectrophotometer at 375 nm.
2.8. Cytotoxicity of nanocomposite (MTT assay)
The cytotoxic effects of the QCN and GO-TEPA-SO3-DRUG against HDF human dermal fibroblast cells and HT29
human colorectal adenocarcinoma cell line were determined through the MTT assay. 7 × 103 cells/well HT29 and 1 ×
104 cells/well HDF were seeded on a 96-well cell culture plate. The culture media was removed and replaced by a solution
containing different concentrations of QCN and GO-TEPA-SO3-DRUG (500, 250, 125, and 62.5 µg mL–1) after 24 h
incubation and cells were incubated for 48 h under standard conditions. The control group was treated with a cell culture
medium only. The incubation culture media was removed after 72 h and each well washed with PBS. Fifty mL of MTT (3(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) solution in PBS (5 mg mL–1) was entered to each well, and
incubated for an additional 4 h. Then, MTT solvent DMSO was added and the absorbance of the solution was recorded at
570 nm (formation of formazan). Finally, the percentage of viability was calculated as the following:
((A 570 nm) sample/((A 570 nm) control) × 100
3. Results and discussion
This study was conducted based on presenting a new graphene oxide nanocomposite which can be utilized in the drug
delivery system. Graphene oxide as one of the favorable and reliable structures was employed and the structure was
modified using the suitable material. The full processes as displayed in Scheme were done using a general synthetic manner
and described in detail previously. To assess the synthesized structure and consideration on its capability in loading and
releases of the drug; at first, spectral and structural characterizations were done. Then, quercetin as a model drug with the
anticancer property was selected and loading, releases and toxicity of the drug on the nanocarrier were studied.
3.1. XRD patterns
The energy dispersive X-ray analyzer (XRD) patterns of GO, GO-TEPA, and GO-TEPA-SO3H are shown in Figure 1. As
a result of abundant oxygen-containing groups, XRD pattern of GO (Figure 1a) shows a sharp peak around the 2θ = 12°.
After surface modification functional of GO with TEPA, since more space was created between layers due to the presence
of TEPA, the diffraction peak shifts to 2θ = 8° (Figure 1b). The XRD patterns of GO-TEPA-SO3H (Figure 1c) compared to

Scheme. represents the synthetic pathway GO-TEPA-SO3H.
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GO- TEPA display a peak shift from 2θ = 10° for GO-TEPA to 2θ = 23° for GO-TEPA-SO3H, that indicate the exfoliation
of GO sheets because of reaction with chlorosulfonic acid. This observation also emphasizes the elimination of functional
groups on the surface of GO and reduction of GO [31–32].
3.2. Thermal stability
The thermal properties of GO, GO-TEPA, and GO-TEPA-SO3H were studied using thermal gravimetric analysis (TGA),
and the findings are presented in Figure 2. The first weight loss for GO (a) was occurred below 100 °C because of the loss
of water. The maximum weight loss for GO (Figure 2a) was observed around 170 °C, which is related to the elimination
of oxygen-containing functional groups on the GO. As clear in curve (a), the ultimate weight loss for GO was 56%. In the
GO-TEPA curve (Figure 2b), the first weight loss under 150 °C is corresponded to the elimination of water in the structure
of the compound, the second happened between 150 °C to 200 °C that assign to the oxygen-containing functional groups,
the third mass loss was occurred higher than 200 °C that related to the decomposition of organic functional groups. In
the TGA curve of GO-TEPA-SO3H (Figure 2c), a first mass loss observed between 50–170 °C was attributed to the water
evaporation in the structure of nanocarrier. The second mass loss after 170 °C is related to the destruction of amino
sulfonic acid and organic functional groups presented in the GO-TEPA-SO3H [30,33–34].
3.3. SEM, EDX, TEM, and AFM Analysis
The GO and GO-TEPA-SO3H surface morphology was shown by scanning electron microscopy (SEM) images (Figure
3a and Figure 3b). These images indicate that the morphology of GO-TEPA-SO3H has been changed compared with GO.
The smooth surface and wrinkled edge morphology were observed in the SEM image of GO. These changes have occurred
probably from the new functional groups that were fixed on the GO surface [30] Also, from the EDX spectra (Figure 3c
and Figure 3d) the presence of (N and S) on GO-TEPA-SO3H after the functionalization is clear. Also, the morphology of

Figure 1. XRD curves of GO (a), GO-TEPA (b), and GO-TEPA-SO3H (c).

Figure 2. TGA patterns of GO (a), GO-TEPA (b), and GO-TEPASO3H (c).
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Figure 3. SEM images of GO (a), GO-TEPA-SO3H (b) and EDX diagram of GO (c), GO- TEPA-SO3H (d).

the GO and GO-TEPA-SO3H nanoparticles were studied by transmission electron microscopy (TEM) and atomic force
microscopy (AFM) techniques. It is clear from Figure 4b that the TEM image of GO-TEPA-SO3H exhibits rough edges
compared with that of GO (Figure 4a). This feature may be created after the functionalization of GO surface. Figure 4c,
Figure 4d and Figure 4e, Figure 4f displays the AFM images of GO and GO-TEPA-SO3H, respectively. The changes in the
size of nanoparticles are evident that proved the probable reaction between GO, amine, and chlorosulphonic acid.
3.4. FT-IR of nanomaterial
The Fourier transform infrared (FTIR) spectra of different samples were displayed in Figure 5. The absorption peaks of GO
(Figure 5a) at around 3440, 1720, 1628, 1168, 1054, and 875 cm–1 are attributed to the stretching vibrations of O-H, C=O,
C=C, C-O, and C-O-C symmetric and asymmetric stretching vibrations, respectively. The spectrum of GO-TEPA (Figure
5b) displayed broad peaks related to the NH and OH stretching vibrations above 3400 cm–1 that overlaps together. The
new peaks were observed between 2800–3000 cm–1 that related to CH2 stretching vibrations. The NH and CN stretching
and bending vibration spectrum were observed at 1554 cm–1 and 1434 cm–1, respectively. The absorption peaks at 1720
cm–1 (C=O stretching), 1054 cm–1 (C-O-C symmetric stretching), and 875 cm–1 (C-O-C asymmetric stretching) were
not observed. These results demonstrated that the tetraethylenepentamine was successfully grafted onto GO [35]. In the
spectrum of GO-TEPA-SO3H (Figure 5c), the introduction of SO3H to the surface of GO-TEPA can be confirmed by
such peaks for stretching vibration of N-SO3H group at 1615 cm–1, asymmetric stretching vibration of SO3 at 1358 cm–1,
and stretching vibration bands at 1247 cm–1 and 776 cm–1 that assign to S=O and S-N groups, respectively [36–37]. In
the spectrum of QCN (Figure 5d) characteristic peaks appeared around 1664 cm–1 (C=O stretching), 1610, and 1521

991

SADEGHI et al. / Turk J Chem

Figure 4. TEM images of GO (a), GO-TEPA-SO3H (b) and AFM images of GO (c,d), GO- TEPA-SO3H(e,f).
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cm–1 (peaks of benzene rings). After loading of QCN on the nanocomposite, in the spectrum GO-TEPA-SO3H-QCN
(Figure 5e) broadband has been observed in areas between 1000–1200 cm–1 and 1500–1700 cm–1, which are probably due
to electrostatic interactions between QCN and nanocomposites and the formation of hydrogen bonding between two
compounds.
3.5. Raman analysis
The Raman spectra for GO, GO-TEPA, and GO-TEPA-SO3H are shown in Figure 6. Raman spectra show two strong
peaks at near 1350 nm (D-band) and 1580 nm (G-band). D-band is a reflection of lattice disorder mainly because of the
breathing mode of aromatic rings and thus may be used as evidence of defect formed by surface functionalization; while
G-band is caused by stretching of the carbon-carbon bond. Therefore, the ratio of intensity of D-band to G-bond (ID/IG) is
an indication of functionalization degree [38–41]. This ratio for GO (Figure 6a) was increased from 0.96 to 1.24 and 1.26
after functionalization to GO-TEPA (Figure 6c) and GO-TEPA-SO3H (Figure 6b), respectively. This result indicates that
functional groups are attached by covalent bonds to the surface of GO during GO-TEPA and GO-TEPA-SO3H synthesis.
4. Study of quercetin loading and release from the nanocarrier
4.1. Drug loading and release behavior
Quercetin as a biological material has a special property such as antioxidant and antiinflammatory that is widely used in
the formulation of anticancer medicine, but its applied dosage is restricted by some intense side effects. Because of the
characteristic and suitable structure, utilizing the GO and modified GO as a carrier of QCN, the side effects of QCN could
be effectively reduced. Therefore, QCN is utilized to test the behavior loading and release of GO and GO-TEPA-SO3H.
With the great ratio of surface to volume, GO and GO-TEPA-SO3H are assumed to be able to load quercetin. As shown

Figure 5. FT-IR spectra of GO(a), GO-TEPA(b), GO-TEPA-SO3H(c),
QCN(d), and GO-TEPA-SO3H-QCN(e).

Figure 6. Raman spectra of GO(a), GO-TEPA-SO3H(b), and GOTEPA(c).
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in Figure 7a, the loading capacity of QCN on GO-TEPA-SO3H incremented with the increase connection time and finally
reached its saturation value when the initial drug concentration was 100 ppm. The maximum loading capacities of QCN
on GO and GO-TEPA-SO3H were up to 33.5 and 45.40 mg g–1, respectively. This behavior of loading is probably related to
the potential of GO and GO-TEPA-SO3H to create hydrogen banding and π-π interaction with QCN. The release test of
QCN from GO and GO-TEPA-SO3H in PBS solution was carried out in pH 1.2 and 7.4 at 37 °C and the results are shown
in Figure 7b and Figure 7c, respectively. In the acidic condition (Figure 7b) the total value of drug released during 96 h
was about 56.44% and 52.68% for GO-TEPA-SO3H and GO, respectively. In an environment with pH 7.4 (Figure 7c), the
quantities of drug released were about 31.19% and 29.61% during the 96 h for GO-TEPA-SO3H and GO, respectively. The
fast QCN release at pH 1.2 was perhaps due to the dissociation of the hydrogen-bonding interaction between the QCN and

Figure 7. Loading percent of QCN on GO and GO-TEPA-SO3H (a). Release profile (b, pH = 1.2 and c, pH = 7.4) of QCN by GO, GOTEPA-SO3H.
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nanocarrier under acidic environment. Nevertheless, these hydrogen-bonding and π-π stacking interactions between the
drug and the nanocarrier are more stable at pH 7.4. Generally, QCN could be loaded on the GO–TEPA-SO3H and released
more in the acidic condition than basic, typical of micro-environments of cancerous tissues. This feature of nanocarrier
provides an ideal mechanism for selective drug release.
4.2. Cytotoxicity of QCN and GO-TEPA- SO3H-QCN nanomaterial
The cytotoxic effect of five concentrations of QCN (0, 62.5, 125, 250, and 500 µg mL–1) was evaluated on HT29 human
colorectal adenocarcinoma cells and HDF human dermal fibroblast as normal cells using MTT assay. As shown in Figure
8a, Figure 8b, and Figure 8c, in comparison with HDF cells, not only concentrations of QCN have more effect on the
viability and morphology but also the increasing of QCN concentration leads to more decreasing in the number of attached
cells on HT29 cells. MTT analysis (Figure 8b) on HT29 cell lines shows a decrease in viability rate of cells by increasing
the QCN concentration and IC50 concentrations of QCN which demonstrated 50% growth inhibition for HT29 cells were

Figure 8. Microscopic images of HT29 and HDF cells after 72 h incubation with different concentrations of QCN (Magnification 20x)
(a), Cytotoxic effect of QCN on viability percentage of HT29 and HDF cells (b), IC50 value of QCN on HT29 and MDF Cells (c) (* = p
< 0.05 and ** = p < 0. 01).
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330 μg mL–1. While the IC50 concentrations of QCN for HDF cells were 500 μg mL–1 and there is a significant difference
between HT29 cells IC50 concentrations (330 μg mL–1) and HDF cells IC50 concentrations (500 μg mL–1) (Figure 8c).
Similarly, Figure 9a shows the same results on the cytotoxic effects of GO-TEPA-SO3H-DRUG on HT29 and HDF. A
decreased viability rate of cells was indicated by MTT analysis on GO-TEPA-SO3H-DRUG treated HT29 cell lines and
IC50 concentration of GO-TEPA-SO3H- DRUG for HT29 cells were 399 μg mL–1 but the IC50 concentrations of GO-TEPASO3H- DRUG for HDF cells were ˃ 500 μg mL–1 and similar to QCN there is significant difference between HT29 cells
IC50 concentrations (399 μg mL–1) and HDF cells IC50 concentrations (˃500 μg mL–1) as observed in Figure 9b and Figure
9c. Consequently, we can say, the GO-TEPA-SO3H-DRUG has the ability for being used in cancer cells therapy without
cytotoxic effect on normal cells in IC50 concentration.

Figure 9. Microscopic images of HT29 and HDF cells after 72 h incubation with different concentrations of GO-TEPA-SO3-DRUG
(Magnification 20x) (a), Cytotoxic effect of GO- TEPA-SO3-DRUG on viability percentages of HT29 and HDF cells (b), IC50 value of
GO- TEPA-SO3-DRUG on HT29 and HDF Cells (c) (* = p < 0.05 and ** = p < 0.01).
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5. Conclusion
In summary, the tetraethylenepentamine (TEPA) and chlorosulfonic acid-functionalized graphene oxide were successfully
prepared from the graphene oxide. It introduced more hydrogen bonding and active sites on the surface of GO to make
proper interactions with quercetin in order to optimize the drug loading. FT-IR, XRD, TGA, SEM, EDX, TEM, and AFM
spectral characterization documented that the TEPA and chlorosulfonic acid were grafted onto the GO. In the case of
initial concentration of QCN at 100 ppm, the nanocarrier influenced an excellent capability of binding anticancer drug
QCN with a high loading percentage up to 90%, and also the drug release from the novel delivery can be controlled by pH
of environment. GO- TEPA-SO3H nanocarrier had faster and more release in acidic pH = 1.2 up to 50% and the release
was about 31% in pH = 7.4. Also, MTT assay for QCN and QCN loaded on GO-TEPA-SO3H nanocarriers on the HDF and
HT29 cells relieved that QCN loaded nanocarrier exhibited more cytotoxicity than free QCN, hence, it can release QCN in
cell medium and import more QCN into cancer cells. Therefore, the nanocarrier can be a proper candidate as a new drug
delivery system with great capacity in cancer therapy.
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